R Orentas

@OrentasR

CureWorks | Seattle Children’s Research Institute

Vrijeme pridruživanja: studeni 2014.

Tweetovi

Blokirali ste korisnika/cu @OrentasR

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @OrentasR

  1. Prikvačeni tweet
    11. stu 2017.

    A man I loved always- to know him even a little was to be deeply influenced by him

    Poništi
  2. 24. sij

    PIs who have 2 or more RO1s taking advice from administrators

    Poništi
  3. proslijedio/la je Tweet
    13. sij
    Odgovor korisnicima

    Don’t know if any of you have tried to report these-it’s a lot of data that isn’t routinely collected in investigator initiated studies and is very time consuming to gather and enter if you’re an investigator. Some NIH bureaucrats came up with this 😐

    Poništi
  4. 13. sij
    Poništi
  5. 10. sij

    Mid-career, early career with evidence of productivity, serious package available for researcher interested in -new space, in vivo models at any scale, clinical appt if desired (MD, DVM), Ben Towne Center for Childhood Cancer Research. SCRI Seattle.

    Poništi
  6. proslijedio/la je Tweet
    10. sij

    After a Scare, Seattle Cracks Down on Vaccine Compliance

    Poništi
  7. proslijedio/la je Tweet

    Barstool Sports has a new Fight With Oskar shirts, where 100% of the net proceeds will go towards the fight against Ewing’s Sarcoma. Buy NOW!

    Poništi
  8. proslijedio/la je Tweet
    2. sij

    "Why having a monopoly on the product combined with a captive market for it does not violate antitrust law is unclear to us."

    Poništi
  9. proslijedio/la je Tweet
    31. pro 2019.

    Thanks Hopes & Smiles for Children for supporting cancer research! Yesterday Dr. Vandana Kalia, Dr. & Dr. Surojit Sarkar gratefully accepted a gift that will bring hope to kids facing & smiles to our entire 's community.

    Poništi
  10. proslijedio/la je Tweet
    31. pro 2019.
    Odgovor korisnicima

    The openxlsx package works like a charm

    Poništi
  11. proslijedio/la je Tweet

    2019 in Review - Our Division recently announced that CAR-T cell production will start soon in support of a multi-center in pediatric acute myeloid leukemia. Read about this exciting project here:

    Poništi
  12. proslijedio/la je Tweet

    Remy and Sadie it was amazing spending time with you and hope you have a Merry Christmas!

    Poništi
  13. proslijedio/la je Tweet
    9. pro 2019.
    Poništi
  14. 9. pro 2019.

    Phil Greenberg delivering the E Donall Thomas lecture at showing us the characteristics of T cells that mediate prevention of AML relapse. An amazing 40 yr tour de force - thank you Phil you inspire us all

    Poništi
  15. proslijedio/la je Tweet
    8. pro 2019.

    ASH power trio! 3 outstanding women in hematology/leukemia/cell therapy. L to R: Rebecca Gardner, Sarah Tasian, and Lia Gore.

    Poništi
  16. 8. pro 2019.

    Dr Ferrari reports on the 9 pts treated with LV for at -notable for chemo regimen to prep and direct injection of CD34 transduced cells into marrow to prevent organ filtering- we are 3 years out- 4 are transfusion independent: correlates trsdctn efficiency

    Poništi
  17. 8. pro 2019.

    The great Feng Zhang developing the next generation of specific genome editors this is why go to ASH

    Poništi
  18. 7. pro 2019.

    You want data? Dr Xian Zhang has data in over 250 patients who got CD19 CART products. No question that in this generation of products HSCT makes a big impact. Impressive data set and presentation!

    Poništi
  19. 7. pro 2019.

    Dr E Stadtmauer presented the amazing success of making an NY-ESO1 TCR via LV and CRISPERed endogenous TCR &PD1-This is why we come to ! Chromosomal translocations were seen in the first set of 3 patients -no doubt we need safety switches

    Poništi
  20. 6. pro 2019.

    How much does CAR-T cost in an academic IND setting : here is the CWRU calculated cost. No excuse to hold back innovation for our patients! excellent talk by Jane Reese

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·